British Journal of Ophthalmology · 2006 · 17 citations · 25 references
MedicineOphthalmologyPharmacologyNeuro-ophthalmologyOcular DiseaseOcular PharmacologyOcular PharmacodynamicsRetinal AnatomyRetinal DegenerationAdenosine Receptor ModulationAdenosine Receptor SignalingGanglion Cell LossIntraocular Pressure ElevationRetinal Ganglion Cell Injury ResponseRetinal LayersRetinal NeuroprotectionRetinal Pharmacology
AIMS: To determine the effect of 2-(6-cyano-1-hexyn-1-yl)adenosine (2-CN-Ado), an adenosine A2A receptor agonist, on retinal ischaemia/reperfusion damage in rats. METHODS: Retinal ischaemia/reperfusion damage was induced by elevating the intraocular pressure of one eye to 130 mm Hg for 60 minutes and returning it to normal. 7 days later, retinal ischaemia/reperfusion damage was histologically quantified by measuring the thickness of retinal layers. Intraocular pressure was measured by pressure transducer. RESULTS: Retinal ischaemia/reperfusion caused cell loss in the ganglion cell layer and thinning of the inner plexiform and nuclear layer. Both ocular topical and intravenous administration of 2-CN-Ado caused a reduction of retinal ischaemia/reperfusion damage. A selective A2A receptor antagonist, 1,3,7-trimethyl-8-(3-chlorostyryl) xanthine (CSC), but not a selective A1 receptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), or a selective A2B receptor antagonist, alloxazine, reduced the protective effect of 2-CN-Ado. While ocular topical administration of 2-CN-Ado caused a sustained reduction of intraocular pressure, intravenous administration of 2-CN-Ado showed a transient ocular hypotensive effect. CONCLUSIONS: These results suggest that 2-CN-Ado attenuates retinal ischaemia/reperfusion damage, and at least some of this protective effect of 2-CN-Ado might be mediated via activation of the adenosine A2A receptor.
25
Akira Matsuda, Misao Shinozaki, Toyofumi Yamaguchi et al. · Journal of Medicinal Chemistry · 1992 · 126 citations · Full text
Experimental ischemia induces cell mitosis in the adult rat retina.
Einar Stefánsson, Charles A. Wilson, Timothy J. Schoen et al. · PubMed · 1988 · 114 citations
Ameliorative Effect of MK-801 on Retinal Ischemia
Tim T. Lam, Edward D. Siew, R. Chu et al. · Journal of Ocular Pharmacology and Therapeutics · 1997 · 95 citations